Skip to main content
logo
Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.08
+0.02 (0.28%)
Oct 12, 2026, 4:00 PM EDT - Market closed

Xilio Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6034421574437
Market Cap Growth
37.00%-19.94%177.26%-79.46%-83.14%-
Enterprise Value
-70-63-11-30-45581
Last Close Price
9.058.9613.377.7037.66224.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.930.776.62---
PB Ratio
0.820.952.380.410.702.36
P/TBV Ratio
0.820.952.380.410.702.36

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.200.460.340.190.11
Net Debt / Equity Ratio
-1.79-3.70-2.68-0.87-0.95-0.96
Net Debt / EBITDA Ratio
4.323.230.810.421.152.41
Net Debt / FCF Ratio
2.1223.702.560.471.292.17
Asset Turnover
0.450.390.10---
Quick Ratio
4.152.532.032.805.7015.50
Current Ratio
4.252.582.213.025.9015.85
Return on Equity (ROE)
-55.03%-132.53%-214.02%-107.25%-60.62%-84.16%
Return on Assets (ROA)
-13.61%-23.24%-56.48%-49.44%-31.20%-36.88%
Return on Capital Employed (ROCE)
-26.10%-42.70%-136.10%-176.00%-75.50%-36.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-36.66%-104.24%-138.74%-504.62%-119.66%-17.33%
FCF Yield
-102.88%-16.39%-43.86%-456.42%-105.24%-18.72%
Buyback Yield / Dilution
-77.75%-18.53%-94.61%-0.38%-388.59%-970.35%
SEC Filings: 10-K · 10-Q